Bangquiao, Arcelyn B.
HRN: 21-32-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2022
CO-AMOXICLAV 625MG (TAB)
05/12/2022
05/18/2022
PO
625mg
BID
Preterm
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes